Aug 1, 1989

Estimating allowable blood loss with correction for variations in blood volume

Acta Anaesthesiologica Scandinavica
R G Hahn

Abstract

All the theoretical relationships between blood loss and change in haematocrit used for calculating the allowable pre-transfusion blood loss assume a strictly normovolaemic situation. In this study a formula was derived in which account was taken of the variation in blood volume. The formula was based on clinical data. Measurements of the blood loss, the blood haemoglobin concentration and the haematocrit (HCT) were performed on 230 occasions in the course of 35 transurethral prostatic resections. The change in blood volume was estimated by the haemoglobin dilution method and the value so obtained was compared to both the measured haematocrit and the theoretical value that would presumably have been recorded if there had been no change in blood volume. The relationship established from these comparisons was: blood loss = preoperative blood volume x [In preop HCT - In postop HCT (1 + 0.15 x blood volume change)].

  • References12
  • Citations10

Mentioned in this Paper

Anesthesia Procedures
Prostate
Hemodilution
Hemoglobin Measurement
Eryhem
Dipstick Assessment of Hemoglobin Concentration
Probability
Hemorrhage
Whole Blood Volume Determination, Including Separate Measurement of Plasma Volume and Red Cell Volume (Radiopharmaceutical Volume-dilution Technique)
Hematocrit Procedure

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

IGA Glomerulonephritis

IgA glomerulonephritis is a chronic form of glomerulonephritis characterized by deposits of predominantly Iimmunoglobin A in the mesangial area. Discover the latest research on IgA glomerulonephritis here.

Cryogenic Electron Microscopy

Cryogenic electron microscopy (Cryo-EM) allows the determination of biological macromolecules and their assemblies at a near-atomic resolution. Here is the latest research.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

LRRK2 & Immunity During Infection

Mutations in the LRRK2 gene are a risk-factor for developing Parkinson’s disease. However, LRRK2 has been shown to function as a central regulator of vesicular trafficking, infection, immunity, and inflammation. Here is the latest research on the role of this kinase on immunity during infection.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Meningococcal Myelitis

Meningococcal myelitis is characterized by inflammation and myelin damage to the meninges and spinal cord. Discover the latest research on meningococcal myelitis here.

Alzheimer's Disease: MS4A

Variants within membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease by recent genome-wide association studies. Here is the latest research.